Thrombosis News and Research

Latest Thrombosis News and Research

Direct oral anticoagulant more effective in lowering risk of VTE after common orthopedic surgeries

The direct oral anticoagulant rivaroxaban dramatically cut the likelihood of serious venous thromboembolism (VTE) in people recovering from lower limb orthopedic surgery requiring immobilization in comparison with enoxaparin, another anticoagulant agent, according to research presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology.

30 Mar 2020

Oral apixaban as effective as dalteparin for treating blood clots in people with cancer

For people with cancer, the oral blood thinner apixaban is at least as effective as dalteparin, a low molecular weight heparin given by injection, in preventing a repeat venous thromboembolism (VTE), or blood clot, with no excess in major bleeding events, according to Phase 3 trial results presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology.

30 Mar 2020

Taking ticagrelor alone better for patients with complex heart disease

Patients with complex heart disease who stopped taking aspirin three months after the insertion of one or more coronary stents and then took the anti-platelet medication ticagrelor alone for a year had fewer episodes of bleeding and no increase in heart attacks, stroke or other adverse events caused by blockages in the arteries, compared with patients who took both aspirin and ticagrelor over the same period.

30 Mar 2020

Low-dose rivaroxaban reduces adverse heart events in symptomatic PAD post-intervention

People with symptomatic peripheral artery disease who took the blood thinner rivaroxaban with aspirin after undergoing a procedure to treat blocked arteries in the leg (lower extremity revascularization) had a 15% reduction in the risk of major adverse limb and cardiovascular events when compared with those receiving aspirin alone, according to research presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology.

30 Mar 2020

HORIBA Medical’s Yumizen G200 hemostasis device validated for use with UK NEQAS BC samples

HORIBA UK Ltd, Medical announces that a study has shown that UK National External Quality Assessment Scheme for Blood Coagulation external quality assessment lyophilized plasma samples can be tested on its Yumizen G200 hemostasis instrument.

From HORIBA Medical 20 Mar 2020

Improving lifestyle habits may be useful additions to management of atrial fibrillation

Weight loss, regular physical activity and other lifestyle changes are effective yet underused strategies that should be added to optimize management of atrial fibrillation (an abnormal heart rhythm), according to "Lifestyle and Risk Factor Modification for Reduction of Atrial Fibrillation," a new Scientific Statement from the American Heart Association published today in the Association's flagship journal Circulation.

9 Mar 2020

Robot that can draw blood in humans

Soon, robots can take blood samples that can benefit both patients and healthcare workers, thanks to a new blood-sampling robot. A few years back, it was developed but was only tested on plastic arms. Now, the robot has been successfully trialed on live humans.

9 Feb 2020

New blood-sampling robot performs as well or better than people

In the future, robots could take blood samples, benefiting patients and healthcare workers alike.

6 Feb 2020

Arterial stiffness accelerates as women transition through menopause

A marker for heart disease risk considerably worsens as women transition through menopause, according to a new analysis from the largest and longest running study of women's health in midlife, the Study of Women's Health Across the Nation.

3 Feb 2020

Study advances the understanding of capillary regression

Many diseases arise from abnormalities in our capillaries, tiny exquisitely branching blood vessel networks that play a critical role in tissue health.

29 Jan 2020

Arginine depletion could form the basis for potential rheumatoid arthritis therapies

A group from the MedUni Vienna has identified a role for the endogenous amino acid arginine in the growth of osteoclasts in rheumatoid arthritis.

23 Jan 2020

Children with peripherally inserted central catheters are more likely to develop blood clots, study shows

A study has found that children inserted with PICCs are at higher risk of developing blood clots called venous thromboembolism.

8 Jan 2020

ACG publishes new guideline on disorders of hepatic and mesenteric circulation

The American College of Gastroenterology is pleased to announce the publication of a new ACG Clinical Guideline on Disorders of Hepatic and Mesenteric Circulation, which was published online today in The American Journal of Gastroenterology.

7 Jan 2020

First reported occurrence and treatment of venous thrombosis during spaceflight

Serena Auñón-Chancellor, M.D., M.P.H., Clinical Associate Professor of Medicine at LSU Health New Orleans School of Medicine's branch campus in Baton Rouge, is the lead author of a paper describing a previously unrecognized risk of spaceflight discovered during a study of astronauts involved in long-duration missions.

2 Jan 2020

African-Americans at higher risk for cancer-associated VTE, study finds

African-Americans are at higher risk for cancer-associated venous thromboembolism (VTE) as compared with patients from other races.

16 Dec 2019

LUNAC-led drug discovery project receives funding under Innovate UK’s Biomedical Catalyst program

LUNAC Therapeutics, a UK based drug discovery company focused on the identification and development of advanced anticoagulants with minimal bleeding risk, today announced that, along with the Medicines Discovery Catapult and the University of Leeds, it has been awarded £3.14M funding under Innovate UK’s Biomedical Catalyst program.

4 Dec 2019

Thrombosis News and Research

Latest Thrombosis News and Research

Direct oral anticoagulant more effective in lowering risk of VTE after common orthopedic surgeries

Oral apixaban as effective as dalteparin for treating blood clots in people with cancer

Taking ticagrelor alone better for patients with complex heart disease

Low-dose rivaroxaban reduces adverse heart events in symptomatic PAD post-intervention

HORIBA Medical’s Yumizen G200 hemostasis device validated for use with UK NEQAS BC samples

Improving lifestyle habits may be useful additions to management of atrial fibrillation

Robot that can draw blood in humans

New blood-sampling robot performs as well or better than people

Arterial stiffness accelerates as women transition through menopause

Study advances the understanding of capillary regression

Arginine depletion could form the basis for potential rheumatoid arthritis therapies

Children with peripherally inserted central catheters are more likely to develop blood clots, study shows

ACG publishes new guideline on disorders of hepatic and mesenteric circulation

First reported occurrence and treatment of venous thrombosis during spaceflight

African-Americans at higher risk for cancer-associated VTE, study finds

LUNAC-led drug discovery project receives funding under Innovate UK’s Biomedical Catalyst program

Researchers find new way to interpret blood tests to diagnose pulmonary embolism

Researchers create new coating to prevent clotting, infection in synthetic vascular grafts

Research could offer new hope for the prevention, treatment of deep vein thrombosis

New study provides better understanding of blood clot formation in cancer patients

Pharmaceutical Manufacturing - Industry Focus eBook eBook

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Thrombosis News and Research

Latest Thrombosis News and Research

Pharmaceutical Manufacturing - Industry Focus eBook eBook

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Newsletters you may be interested in